RADICAVA
Google image searchProduct monograph
Active ingredient
edaravone, 30 MG/100 ML
DIN: 02475472
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: MITSUBISHI TANABE PHARMA CORPORATION
Date: 29-OCT-2019
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07X — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD)
- N07XX — Other nervous system drugs (ATC, ATC/DDD)
- N07XX14 — EDARAVONE (ATC/DDD)
